Stock Events

Stock Events

OncoSil Medical 

$0
5
+$0+0% Monday 13:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
92,169
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24FebExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.77
-0.43
-0.1
0.23
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,287.47%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.52MRevenue
-19.6MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OCMLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Elekta AB
EKTAY
Mkt Cap1.95B
Elekta AB provides equipment and software for cancer treatment, including brachytherapy which is similar to OncoSil Medical's targeted radiation therapy.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical offers robotic surgical solutions, often used in the treatment of cancers, competing with OncoSil's approach in terms of offering minimally invasive options.
Baxter International
BAX
Mkt Cap9.49B
Baxter International produces medical devices and pharmaceuticals that are used in the treatment of various cancers, overlapping with OncoSil Medical's market.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops medical devices that are used in various interventional medical specialties, including oncology.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc provides medical technologies, services, and solutions, including cancer treatments that compete with OncoSil Medical's offerings.
Sensus Healthcare
SRTS
Mkt Cap52.44M
Sensus Healthcare focuses on non-invasive treatments of non-melanoma skin cancers and keloids with superficial radiation therapy, competing in the radiation therapy space.
Accuray
ARAY
Mkt Cap158.94M
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for alternative cancer treatments.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. provides healthcare solutions that, while primarily focused on orthopedics, also offers products that can be used in surgical oncology, indirectly competing with OncoSil Medical.

About

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
Show more...
CEO
Country
AU
ISIN
AU000000OSL3

Listings

OTC Link
US
OCMLF
AU
AU
OSL.AU

0 Comments

Share your thoughts

FAQ

What is OncoSil Medical stock price today?▼
The current price of OCMLF is $0 USD — it has increased by +0% in the past 24 hours. Watch OncoSil Medical stock price performance more closely on the chart.
What is OncoSil Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange OncoSil Medical stocks are traded under the ticker OCMLF.
What is OncoSil Medical market cap?▼
Today OncoSil Medical has the market capitalization of 92,169
When is the next OncoSil Medical earnings date?▼
OncoSil Medical is going to release the next earnings report on August 27, 2026.
What is OncoSil Medical revenue for the last year?▼
OncoSil Medical revenue for the last year amounts to 1.52M USD.
What is OncoSil Medical net income for the last year?▼
OCMLF net income for the last year is -19.6M USD.
In which sector is OncoSil Medical located?▼
OncoSil Medical operates in the Professional, Scientific, and Technical Services sector.
When did OncoSil Medical complete a stock split?▼
The last stock split for OncoSil Medical was on June 03, 2025 with a ratio of 1:400.